Tag: canopy growth earnings

Canada is gearing up for Cannabis 2.0, a second legalization phase for alternative cannabis products scheduled for October 17.

The consensus target price for Cronos Group stock fell to 19.88 Canadian dollars from 20.3 Canadian dollars in August, which represents a fall of ~2.07%.

Cresco Labs (CRLBF) is all set to report its second-quarter results after the market closes today. Cresco stock tanked 6.9% yesterday.

Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.

The cannabis industry has become a favorite among investors. The industry saw a boom due to easing regulations. Major players have shown growth potential.

Canopy Growth (WEED)(CGC) was trading 3% higher early this morning after it announced the receipt of a key extraction license.

Bernie Sanders tweeted his support for legalizing marijuana nationally and expunging past marijuana convictions. How could this impact cannabis stocks?

Cannabis companies face regulatory challenges. Recently, CannTrust (CTST) didn't comply with Health Canada’s regulations.

Canopy Growth didn't impress investors with its earnings for the first quarter of 2020. The stock has fallen 12.4% since the company's earnings.